NewsBenzinga바이킹 테라퓨틱스, 일요일 발표···피하주사형 VK2735 투여군의 74%가 13주 후 BMI 범주 개선, 위약군은 15%에 그쳐, 심혈관 대사 지표도 개선 바이킹 테라퓨틱스, 일요일 발표···피하주사형 VK2735 투여군의 74%가 13주 후 BMI 범주 개선, 위약군은 15%에 그쳐, 심혈관 대사 지표도 개선 Benzinga 2026.11.16 05:21 (GMT+0) Open on Benzinga Other news Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? Clorox Stock Outlook: Is Wall Street Bullish or Bearish? Shorting ConocoPhillips Puts and Put Credit Spreads Are Attractive Income Plays Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report How To Earn $500 A Month From Target Stock Ahead Of Q3 Earnings Stifel Reinstates Buy on Walmart, Announces $145 Price Target
Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report